======= MSC ======= == Gene Information == * **Official Symbol**: MSC * **Official Name**: musculin * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9242|9242]] * **UniProt**: [[https://www.uniprot.org/uniprot/O60682|O60682]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MSC&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MSC|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603628|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Transcription repressor capable of inhibiting the transactivation capability of TCF3/E47. May play a role in regulating antigen-dependent B-cell differentiation. |HLH| |branchiomeric skeletal muscle development| |diaphragm development| |roof of mouth development| |cellular response to leukemia inhibitory factor| |response to leukemia inhibitory factor| |RNA polymerase II distal enhancer sequence-specific DNA binding| |skeletal muscle tissue development| |skeletal muscle organ development| |protein dimerization activity| |respiratory system development| |transcription corepressor activity| |DNA-binding transcription repressor activity, RNA polymerase II-specific| |striated muscle tissue development| |muscle organ development| |muscle tissue development| |muscle structure development| |transcription by RNA polymerase II| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |DNA-binding transcription factor activity| |negative regulation of transcription by RNA polymerase II| |cellular response to cytokine stimulus| |nucleobase-containing compound biosynthetic process| |response to cytokine| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |organic cyclic compound biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |cellular nitrogen compound biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |negative regulation of gene expression| |tissue development| |macromolecule biosynthetic process| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp229|Dimethyloxaloylglycine 100μM R05 exp229]]|1.74| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 1/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6275 * **Expression level (log2 read counts)**: -7.68 {{:chemogenomics:nalm6 dist.png?nolink |}}